S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
[Urgent!] Generational Wealth Gameplan (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
The “Perfect Storm” for Gold (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
[Urgent!] Generational Wealth Gameplan (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
The “Perfect Storm” for Gold (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
[Urgent!] Generational Wealth Gameplan (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
The “Perfect Storm” for Gold (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
[Urgent!] Generational Wealth Gameplan (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
The “Perfect Storm” for Gold (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Free Trial
CVE:VM

Voyageur Pharmaceuticals (VM) Stock Price, News & Analysis

→ Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad)
Free VM Stock Alerts
C$0.06
+0.01 (+22.22%)
(As of 05:34 PM ET)
Compare
Today's Range
C$0.06
▼
C$0.06
50-Day Range
C$0.05
▼
C$0.09
52-Week Range
C$0.04
▼
C$0.09
Volume
27,900 shs
Average Volume
104,479 shs
Market Capitalization
C$7.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartHeadlines
VM stock logo

About Voyageur Pharmaceuticals Stock (CVE:VM)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.

VM Stock Price History

VM Stock News Headlines

March 13, 2024 | proactiveinvestors.com
Voyageur Pharmaceuticals executes royalty agreement with Rain Cage Carbon
January 3, 2024 | morningstar.com
Voyageur Pharmaceuticals Ltd VM
April 17, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
December 21, 2023 | stockhouse.com
Voyageur Pharmaceuticals Ltd Announces Deferred Share Unit (DSU) Grant to Directors
December 8, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd up on Thursday (VM)
October 24, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd up on Monday (VM)
September 14, 2023 | stockhouse.com
Voyageur Pharmaceuticals Achieves Milestone in the Development of HDXBa Barium Contrast Media
September 14, 2023 | proactiveinvestors.com
Voyageur Pharmaceuticals achieves milestone developing HDXBa barium contrast media
April 17, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
September 7, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd up on Wednesday (VM)
June 20, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd down on Tuesday (VM)
May 31, 2023 | proactiveinvestors.com
Voyageur Pharmaceuticals completes field work at Frances Creek project in British Columbia
May 24, 2023 | finance.yahoo.com
Voyageur Pharmaceuticals Partners with Rain Cage Carbon to Revolutionize Medical Imaging with Nanocarbon-Based Contrast Drugs
May 24, 2023 | proactiveinvestors.com
Voyageur Pharmaceuticals unveils pioneering agreement with Rain Cage Carbon
May 10, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd flat on Tuesday (VM)
May 4, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd flat on Wednesday (VM)
May 2, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd down on Monday (VM)
April 29, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd up on Friday (VM)
April 28, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd flat on Thursday (VM)
April 26, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd flat on Monday (VM)
April 22, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd flat on Friday (VM)
April 21, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd down on Thursday (VM)
April 14, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd down on Friday (VM)
April 8, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd down on Wednesday (VM)
April 6, 2023 | theglobeandmail.com
Closing Bell: Voyageur Pharmaceuticals Ltd up on Tuesday (VM)
April 4, 2023 | proactiveinvestors.com
Voyageur Pharmaceuticals reports positive comparative study of SmoothX barium contrast media for CT imaging
February 14, 2023 | proactiveinvestors.com
Voyageur Pharmaceuticals preparing to launch sales of its first product in Canada
See More Headlines
Receive VM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Voyageur Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:VM
CUSIP
N/A
CIK
N/A
Web
www.voyageurminerals.ca
Phone
587-779-6166
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
C($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-1,400,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-96.50%
Return on Assets
-35.90%

Debt

Debt-to-Equity Ratio
2.79
Current Ratio
0.13
Quick Ratio
0.84

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.00 per share
Price / Cash Flow
35.00
Book Value
C$0.01 per share
Price / Book
5.50

Miscellaneous

Outstanding Shares
138,810,000
Free Float
N/A
Market Cap
C$7.63 million
Optionable
Not Optionable
Beta
0.49
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Brent Willis Bsc.Eng (Age 53)
    President, CEO & Director
    Comp: $131k
  • Mr. Bradley Craig Willis P.Eng. (Age 53)
    Founder, COO & Director
    Comp: $125.5k
  • Mr. Albert Deslauriers
    Chief Financial Officer

Key Competitors

View All Competitors

VM Stock Analysis - Frequently Asked Questions

How have VM shares performed in 2024?

Voyageur Pharmaceuticals' stock was trading at C$0.08 at the start of the year. Since then, VM stock has decreased by 26.7% and is now trading at C$0.06.
View the best growth stocks for 2024 here.

What other stocks do shareholders of Voyageur Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Voyageur Pharmaceuticals investors own include Agile Therapeutics (AGRX), Sierra Oncology (SRRA), Achillion Pharmaceuticals (ACHN), LINE (LN), Littelfuse (LFUS), Howard Hughes (HHC), EQT (EQT), Deckers Outdoor (DECK), Cranswick (CWK) and Cirrus Logic (CRUS).

How do I buy shares of Voyageur Pharmaceuticals?

Shares of VM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:VM) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
The “Perfect Storm” for Gold
Gold Safe Exchange
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Options trading has suddenly become more reliable.
Eagle Publishing
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Top 5 Tech Stocks to Buy for 2024
Daily Market Alerts
You won't believe what Citigroup just did to it's depositors
American Alternative